| Breakdown | TTM | Dec 2024 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.63B | 107.55B | 120.03B | 90.10B | 77.75B | 61.51B |
| Gross Profit | 78.81B | 69.05B | 78.23B | 58.83B | 51.08B | 41.47B |
| EBITDA | 28.21B | 31.73B | 29.02B | 26.73B | 23.34B | 18.20B |
| Net Income | 10.53B | 15.81B | 12.74B | 13.11B | 10.86B | 9.98B |
Balance Sheet | ||||||
| Total Assets | 182.69B | 191.61B | 193.19B | 172.64B | 155.13B | 115.43B |
| Cash, Cash Equivalents and Short-Term Investments | 45.94B | 38.66B | 54.20B | 36.88B | 32.32B | 21.36B |
| Total Debt | 3.30B | 6.70B | 11.10B | 14.25B | 12.18B | 8.04B |
| Total Liabilities | 30.71B | 39.65B | 41.83B | 38.35B | 34.00B | 22.49B |
| Stockholders Equity | 151.19B | 151.22B | 150.56B | 132.31B | 119.46B | 92.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 24.83B | 32.45B | 6.85B | 9.32B | -986.00M |
| Operating Cash Flow | 0.00 | 34.71B | 40.54B | 19.14B | 17.30B | 8.92B |
| Investing Cash Flow | 0.00 | -21.22B | -13.43B | -15.13B | -18.70B | -16.33B |
| Financing Cash Flow | 0.00 | -13.88B | -8.11B | -2.34B | 11.37B | 10.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $2.13T | 19.23 | 14.88% | 1.07% | 0.59% | 557.87% | |
70 Outperform | ¥3.69T | 29.54 | 9.17% | 1.12% | 7.58% | 6.74% | |
69 Neutral | $667.11B | 52.35 | 8.67% | 1.01% | 11.60% | -19.38% | |
64 Neutral | $173.65B | 20.85 | 28.56% | 1.59% | 17.13% | 78.33% | |
63 Neutral | $1.06T | 22.55 | 9.80% | 1.74% | 1.51% | -12.59% | |
62 Neutral | ¥242.20B | 42.06 | 2.49% | 2.02% | 8.83% | -40.24% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Asahi Intecc Co., Ltd. has completed the acquisition of 1,206,800 treasury shares, amounting to approximately 2.85 billion yen, as part of a broader plan approved by the Board of Directors in May 2025. This strategic move, which concluded on October 30, 2025, is part of the company’s efforts to enhance shareholder value and optimize its capital structure, having acquired a total of 6,301,300 shares by the end of the acquisition period.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2525.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc Co., Ltd. has announced the acquisition of 730,200 treasury shares at a total cost of 1,941,250,993 yen during September 2025. This acquisition is part of a larger plan approved by the Board of Directors to acquire up to 8,800,000 shares by October 31, 2025, with a maximum expenditure of 15,000 million yen. The acquisition of treasury shares is a strategic move that may impact the company’s stock value and shareholder equity.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2632.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc Co., Ltd. has announced the acquisition of 1,028,700 of its own shares at a total cost of 2,588,314,199 yen, as part of a broader plan to acquire up to 8,800,000 shares by October 31, 2025. This move is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value, reflecting a proactive approach in managing its financial resources.
The most recent analyst rating on (JP:7747) stock is a Buy with a Yen2829.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc Co., Ltd. is a Japanese company listed on the Tokyo and Nagoya Stock Exchanges, specializing in the development, manufacturing, and sales of medical devices and components, with a focus on the cardiovascular field.
Asahi Intecc Co., Ltd. has announced a new medium-term management plan titled ‘Building the Future 2030 ~Unlocking Sustainable Growth~,’ outlining its strategic goals for the next five years. The plan aims to re-accelerate growth by enhancing profitability of existing businesses and preparing for new business ventures, with a target of achieving consolidated net sales of 180 billion yen and an operating profit margin of 28% by 2030. This initiative is expected to strengthen the company’s global market position and support its long-term vision of becoming a comprehensive solutions provider in the minimally invasive treatment field.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2440.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc Co., Ltd. reported its consolidated financial results for the fiscal year ending June 30, 2025, showing a significant increase in net sales and operating profit, despite a decrease in profit attributable to owners of the parent. The company experienced a notable rise in cash flows from operating activities, highlighting its strong operational performance. The financial results underscore Asahi Intecc’s robust market position and strategic growth in the medical device sector, with implications for continued investor confidence and market expansion.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen2440.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.
Asahi Intecc Co., Ltd. has announced the acquisition of 1,378,900 treasury shares, amounting to approximately 3.17 billion yen, during July 2025. This move is part of a broader plan approved by the Board of Directors to acquire up to 8.8 million shares by October 2025, reflecting a strategic effort to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:7747) stock is a Hold with a Yen1900.00 price target. To see the full list of analyst forecasts on Asahi Intecc Co stock, see the JP:7747 Stock Forecast page.